Subscribe To
Final trades: biotech, defense, thermo fisher & more
The "Halftime Report" traders give their top picks to watch for the second half....
April 13, 2023, 2:21 pm
Willow biosciences launches bio-oxidation platform technology biooxi
Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) has announced the launch of BioOxi, a bio-oxidation platform technology that is complementary to the c...
April 13, 2023, 7:51 am
Gain therapeutics appoints c. evan ballantyne as chief financial officer
BETHESDA, Md., April 12, 2023 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company ...
April 12, 2023, 8:30 pm
Sana biotechnology announces preclinical data published in science translational medicine showing its hypoimmune pancreatic islet cells evaded allogeneic and autoimmune rejection and controlled type 1
Hypoimmune human islet cells normalized glucose in diabetic humanized immunocompetent mouse model and avoided allogeneic and autoimmune rejection by t...
April 12, 2023, 8:05 pm
Sana biotechnology announces preclinical data published in science translational medicine showing its hypoimmune pancreatic islet cells evaded allogeneic and autoimmune rejection and controlled type 1
Hypoimmune human islet cells normalized glucose in diabetic humanized immunocompetent mouse model and avoided allogeneic and autoimmune rejection by t...
April 12, 2023, 8:05 pm
Maia biotechnology (maia) up on positive data from nsclc study
MAIA Biotechnology (MAIA) gains on encouraging data on lead candidate from Part A of its mid-stage study in advanced non-small cell lung cancer....
April 12, 2023, 3:57 pm
Astrazeneca earnings per share forecasts raised by barclays
AstraZeneca PLC (LSE:AZN) saw its full-year earnings per share forecasts raised by Barclays analysts, despite hints that upcoming trial updates were �...
April 12, 2023, 10:52 am
Aerovate: small mid-stage biotech targeting multibillion-dollar pah market
AVTE reported Q4 2023 earnings in line with expectations and has enough cash runway until H2 2025. AV-101, AVTE's lead asset, is on track with patient...
April 12, 2023, 8:45 am
Halozyme's enhanze technology is the future of biologics delivery
Halozyme Therapeutics (HALO) is a biotech company with a unique platform technology, ENHANZE, that allo...
April 12, 2023, 7:38 am
Oncolytics biotech® to participate in a panel presentation at canaccord genuity's horizons in oncology virtual conference
SAN DIEGO and CALGARY, AB , April 12, 2023 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that Chief Medical Off...
April 12, 2023, 7:23 am
biotech stock surging as analyst predicts strong sales
TG Therapeutics Inc ( NASDAQ:TGTX) stock is on a tear, last seen up 17.7% to trade at $22.38, after yesterday adding 22.8% to for its best single-day ...
April 11, 2023, 3:20 pm
Moderna withholds declaring ‘early success' for its influenza vaccine
Shares of Moderna Inc (NASDAQ: MRNA) are trading down on Tuesday after the biotechnology company said it did not have enough data to declare “early ...
April 11, 2023, 11:54 am
Moderna stock falls after vaccines update
The biotech company is working on new drugs for Lyme disease and Covid-19 as it prepares to roll out si...
April 11, 2023, 11:48 am
3 biotech stocks to watch for potential breakthroughs
biotech stock fortunes hinge upon potential, progress, and the ultimate realization of drugs and device...
April 11, 2023, 9:46 am
Henry schein (hsic) acquires majority stake in biotech dental
Henry Schein (HSIC) announces that the completion of the biotech Dental partnership brings forth the co...
April 11, 2023, 9:07 am
Moderna stock slides despite positive vaccines update. here's why.
The biotech company is working on new drugs for Lyme disease and Covid-19 as it prepares to roll out si...
April 11, 2023, 8:57 am
Generation bio to present at the 22nd annual needham virtual healthcare conference
CAMBRIDGE, Mass., April 11, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people...
April 11, 2023, 7:30 am
Foghorn therapeutics to present preclinical data from its selective cbp and ep300 protein degrader programs and preclinical data for fhd-286, a potent, selective inhibitor of brg1 and brm, at the 2023
CAMBRIDGE, Mass., April 10, 2023 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a n...
April 10, 2023, 4:05 pm
Us drugmakers call for reversal of texas abortion pill ruling
More than 300 biotechnology and pharmaceutical executives have signed an open letter calling for a federal judge to reverse their decision to suspend ...
April 10, 2023, 3:51 pm
Top-notch biotech tg therapeutics logs 'solid jump' in sales; shares rocket
TG Therapeutics' new MS drug, Briumvi, experienced a "solid jump" in March sales, according to a report. TGTX stock flew on Monday....
April 10, 2023, 1:23 pm